v1
Response to the comparison of generic zidovudine plus lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets.
Identifier:nobleid.org/w1/20260515/450DDBFE
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/450DDBFE)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims